Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Feb 24, 2022
Open Peer Review Period: Feb 24, 2022 - Apr 21, 2022
Date Accepted: Jun 28, 2022
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial

Sysko R, Bibeau J, Boyar A, Costello K, Michaelides A, Mitchell ES, Susanin A, Hildebrandt T

A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2022;11(8):e37541

DOI: 10.2196/37541

PMID: 35969439

PMCID: 9419047

A Protocol for a 2.5 Year Weight Management Program using Noom Health: Randomized Controlled Trial

  • Robyn Sysko; 
  • Jessica Bibeau; 
  • Allison Boyar; 
  • Kayla Costello; 
  • Andreas Michaelides; 
  • Ellen Siobhan Mitchell; 
  • Annabel Susanin; 
  • Tom Hildebrandt

ABSTRACT

Background:

Overweight and obesity are serious public health concerns. As the prevalence of excess weight among individuals continues to increase, there is a parallel need for inexpensive, highly accessible, and evidence-based weight loss programs.

Objective:

This weight loss trial will examine the efficacy of the Noom weight-loss program in comparison to a digital health control after a 6-month intervention phase and a 24-month maintenance phase with assessments occurring for two-years beyond the intervention (to 30 months post-baseline). Secondary outcomes include quality of life, psychosocial functioning, sleep quality, physical activity, diet, and health status. This trial will also examine severity of obesity-related functional impairment, weight loss history, and demographic moderators along with adherence and self-efficacy as mediators of outcome.

Methods:

A total of 600 participants were randomized in a parallel group-controlled trial to either Noom Healthy Weight Program (intervention) or Noom Healthy Weight Control (control) for a 6-month intervention. Both the intervention and control include diet and exercise recommendations, daily logging capabilities, and daily weigh-in entries. The Noom Healthy Weight Program also includes coach support for weight loss. Remote follow-up assessments of eating, physical activity, psychosocial factors, app use data, and weight will occur at 1-, 4-, 6-, 12-, 18-, 24-, and 30-months post-baseline. Weight is measured at each follow-up point during a Zoom call using the participants’ own scale.

Results:

Enrollment began in March 2021 and the 6-month intervention phase is expected to end for all participants in March 2022. Data collection for the final assessment will be completed in March 2024.

Conclusions:

This study tests commercially available digital lifestyle-intervention for individuals with overweight and obesity seeking weight loss support. Data obtained from the study will evaluate whether the Noom Healthy Weight Control Program can help individuals overcome weight loss, achieve long-term maintenance, adhere to lifestyle changes, and feature-use barriers that are present in other traditional weight loss treatments. Clinical Trial: A ClinicalTrials.gov record (NCT04797169) was created prior to the start of enrollment.


 Citation

Please cite as:

Sysko R, Bibeau J, Boyar A, Costello K, Michaelides A, Mitchell ES, Susanin A, Hildebrandt T

A 2.5-Year Weight Management Program Using Noom Health: Protocol for a Randomized Controlled Trial

JMIR Res Protoc 2022;11(8):e37541

DOI: 10.2196/37541

PMID: 35969439

PMCID: 9419047

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.